Wordt geladen...
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated platelet destruction and decreased platelet production. Rituximab, a B cell–depleting agent, has become the first-line treatment for ITP; however, patients with refractory disease usually require splenectomy. We iden...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3533302/ https://ncbi.nlm.nih.gov/pubmed/23241960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI65689 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|